SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001388410-18-000041
Filing Date
2018-08-31
Accepted
2018-08-30 21:18:29
Documents
125
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT 20170630prlxform10qa.htm 10-Q/A 23928
8 IMAGE f20170630prlxform10qa1.jpg GRAPHIC 58416
  Complete submission text file 0001388410-18-000041.txt   5914054

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prlx-20170630_cal.xml EX-101.CAL 32097
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prlx-20170630_def.xml EX-101.DEF 268670
4 XBRL INSTANCE DOCUMENT prlx-20170630.xml EX-101.INS 1361988
5 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT prlx-20170630_lab.xml EX-101.LAB 566746
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prlx-20170630_pre.xml EX-101.PRE 438888
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prlx-20170630.xsd EX-101.SCH 134573
Mailing Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401
Business Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401 310-899-4442
PARALLAX HEALTH SCIENCES, INC. (Filer) CIK: 0001388410 (see all company filings)

IRS No.: 464733512 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-52534 | Film No.: 181048365
SIC: 5912 Retail-Drug Stores and Proprietary Stores